What is the appropriate workup for tachyarrhythmia in a pediatric patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Workup for Tachyarrhythmia in Pediatric Patients

The workup for pediatric tachyarrhythmia begins with immediate assessment of hemodynamic stability, followed by obtaining a 12-lead ECG to differentiate narrow-complex from wide-complex tachycardia, which fundamentally determines the diagnostic and therapeutic approach 1, 2.

Initial Assessment and Stabilization

Assess hemodynamic status immediately - determine if the child has signs of poor perfusion (altered mental status, weak pulses, delayed capillary refill, hypotension). This dictates whether you proceed with emergent treatment or have time for diagnostic workup 1, 2.

  • If hemodynamically unstable: Proceed directly to synchronized cardioversion (0.5-1 J/kg, escalate to 2 J/kg if unsuccessful) after sedation if possible 1
  • If hemodynamically stable: You have time for systematic diagnostic evaluation

Core Diagnostic Workup

Obtain 12-Lead ECG

This is your most critical diagnostic tool 2, 3:

Measure QRS duration to categorize the rhythm:

  • Narrow-complex (<0.09 seconds): Most likely supraventricular tachycardia (SVT)
  • Wide-complex (>0.09 seconds): Could be ventricular tachycardia, SVT with aberrancy, or SVT with accessory pathway conduction

Analyze specific ECG features:

  • Heart rate (typically 180-300 bpm in SVT in infants, 140-250 bpm in older children)
  • P wave presence, morphology, and relationship to QRS
  • QRS morphology and axis
  • Regularity of rhythm
  • Look for AV dissociation (suggests ventricular tachycardia)

Additional Diagnostic Studies

Laboratory evaluation 1:

  • Electrolytes (potassium, magnesium, calcium) - critical as abnormalities can precipitate or perpetuate arrhythmias
  • Blood glucose - hypoglycemia can trigger arrhythmias
  • Troponin if myocarditis suspected
  • Thyroid function if clinically indicated
  • Drug levels if on antiarrhythmic medications or concern for ingestion

Continuous cardiac monitoring - essential to capture rhythm changes and response to interventions 2, 3.

Echocardiography - perform when stable to assess:

  • Structural heart disease
  • Ventricular function
  • Evidence of cardiomyopathy
  • Congenital anomalies

Narrow-Complex Tachycardia Workup

Differentiate sinus tachycardia from SVT 2:

Sinus tachycardia characteristics:

  • Rate varies with activity/stimulation
  • Normal P wave axis
  • P waves precede each QRS
  • Rate typically <220 bpm in infants, <180 bpm in children
  • Search for underlying cause: fever, pain, hypovolemia, sepsis, hypoxia, anemia, hyperthyroidism

SVT characteristics:

  • Abrupt onset/termination
  • Fixed rate (doesn't vary with stimulation)
  • Rate typically >220 bpm in infants, >180 bpm in children
  • P waves may be absent, retrograde, or buried in QRS

Wide-Complex Tachycardia Workup

This requires careful evaluation as it may represent life-threatening ventricular tachycardia 1, 2, 4:

Features suggesting ventricular tachycardia:

  • AV dissociation
  • Capture or fusion beats
  • Very wide QRS (>0.12 seconds)
  • Extreme axis deviation
  • Specific morphology patterns (concordance in precordial leads)

Features suggesting SVT with aberrancy:

  • Prior history of SVT
  • Identical to prior documented SVT
  • Response to adenosine

Critical caveat: In hemodynamically unstable wide-complex tachycardia, treat as ventricular tachycardia - proceed with synchronized cardioversion rather than spending time on detailed diagnosis 1.

Extended Workup for Recurrent or Concerning Arrhythmias

Ambulatory monitoring 3, 5:

  • 24-48 hour Holter monitor for frequent symptoms
  • Event monitor for infrequent symptoms
  • Document correlation between symptoms and rhythm

Exercise stress testing - if arrhythmia is exercise-induced or concern for catecholaminergic polymorphic ventricular tachycardia 6, 7.

Genetic testing - consider when:

  • Family history of sudden cardiac death
  • Suspected channelopathy (long QT syndrome, Brugada syndrome, catecholaminergic polymorphic VT)
  • Unexplained syncope with arrhythmia
  • Structural abnormalities suggesting inherited cardiomyopathy

Cardiac MRI - valuable for:

  • Detecting myocardial inflammation (myocarditis)
  • Identifying arrhythmogenic substrate
  • Evaluating cardiomyopathies
  • Assessing for fibrosis or scar

Age-Specific Considerations

Infants:

  • SVT is most common tachyarrhythmia
  • May present with poor feeding, irritability, or heart failure rather than palpitations
  • Never use verapamil in infants - can cause severe hypotension, myocardial depression, and cardiac arrest 1, 8

Older children and adolescents:

  • Can describe palpitations more reliably
  • Consider accessory pathway-mediated tachycardias
  • Evaluate for drug use (stimulants, energy drinks)

Common Pitfalls to Avoid

  1. Mistaking sinus tachycardia for SVT - always search for underlying causes of sinus tachycardia before treating as primary arrhythmia
  2. Using verapamil in infants - this is contraindicated and potentially lethal 1
  3. Delaying cardioversion in unstable patients - hemodynamic instability takes precedence over detailed diagnosis
  4. Assuming wide-complex tachycardia is SVT with aberrancy - when in doubt, treat as ventricular tachycardia
  5. Missing underlying structural heart disease or channelopathy - always obtain echocardiogram and consider genetic evaluation in appropriate cases

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.